Researchers link supplement to reduced biomarkers of Alzheimer's

For the first time, a researcher at the University of Delaware College of Health Sciences in collaboration with a team at the National Institute on Aging, a division of the National Institutes of Health, has determined that the naturally occurring dietary supplement known as nicotinamide riboside (NR) can enter the brain.

Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs

Treatment biomarkers for ADHD: Taking stock and moving forward

Natural dietary supplement successfully treats Alzheimers disease

Researchers link supplement to reduced Alzheimer's biomarkers

Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease

Connecting a common dietary supplement to reduced biomarker levels of Alzheimer's disease in the brain - Bioanalysis Zone

Alzheimer's Biomarker Researchers Suggest Caution with Dietary Supplement

Frontiers Nanomedicine: A Promising Way to Manage Alzheimer's Disease

Frontiers Nicotinamide as potential biomarker for Alzheimer's disease: A translational study based on metabolomics

Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic

IJMS, Free Full-Text

Biomarkers in drug discovery and development

The association between omega-3 polyunsaturated fatty acid intake and reduced risk of Alzheimer's disease

Antioxidants, Free Full-Text